Szafrańska B, Ziecik A J
Department of Animal Physiology, University of Agriculture and Technology, Olsztyn/Poland.
Exp Clin Endocrinol. 1990 Dec;96(3):321-4. doi: 10.1055/s-0029-1211027.
Plasma concentrations of prolactin, luteinizing hormone (LH) and progesterone were determined in pregnant gilts (n = 6) administered bromocriptine from 67-72 days of pregnancy. Blood samples were taken daily at 2 h intervals from 60 to 80 days of pregnancy. Bromocriptine treatment reduced prolactin from 9.7 +/- 1.4 before to 1.9 +/- 0.6 ng/ml during the treatment (p less than or equal to 0.05) and then returned to the pre-treatment concentrations (10.5 +/- 2.0) following cessation of bromocriptine. Bromocriptine increased LH from 1.4 +/- 0.2 before treatment to 2.9 +/- 0.5 ng/ml (p less than or equal to 0.01) during administration and maintained elevated (3.0 +/- 0.7) in the post-treatment period (p less than or equal to 0.05). Administration of bromocriptine did not alter progesterone concentration in plasma (7.5 +/- 1.2; 7.2 +/- 1.6 and 6.6 +/- 1.6 ng/ml in pretreatment, treatment and post-treatment periods, respectively). This study shows that decrease of prolactin level by bromocriptine treatment does not cause depletion of progesterone secretion in late pregnant pigs.
在妊娠67至72天的妊娠后备母猪(n = 6)中测定催乳素、促黄体生成素(LH)和孕酮的血浆浓度。在妊娠60至80天期间,每隔2小时采集一次血样。溴隐亭治疗使催乳素水平从治疗前的9.7±1.4降至治疗期间的1.9±0.6 ng/ml(p≤0.05),停用溴隐亭后又恢复到治疗前浓度(10.5±2.0)。溴隐亭使LH从治疗前的1.4±0.2升高至给药期间的2.9±0.5 ng/ml(p≤0.01),并在治疗后维持升高水平(3.0±0.7)(p≤0.05)。给予溴隐亭未改变血浆中孕酮浓度(预处理期、治疗期和治疗后期分别为7.5±1.2、7.2±1.6和6.6±1.6 ng/ml)。本研究表明,溴隐亭治疗降低催乳素水平不会导致妊娠后期母猪孕酮分泌减少。